{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T03:22:49Z","timestamp":1648524169632},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["tcmonline.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.tcm.2014.06.001","type":"journal-article","created":{"date-parts":[[2014,6,8]],"date-time":"2014-06-08T01:15:13Z","timestamp":1402190113000},"page":"225-231","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mechanical closure devices for atrial fibrillation"],"prefix":"10.1016","volume":"24","author":[{"given":"Matthew J.","family":"Price","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.tcm.2014.06.001_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2014.06.001_bib2","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults","volume":"285","author":"Go","year":"2001","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.tcm.2014.06.001_bib3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0735-1097(99)00489-1","article-title":"Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. stroke prevention in atrial fibrillation investigators","volume":"35","author":"Hart","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2014.06.001_bib4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","article-title":"Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis","volume":"131","author":"Hart","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tcm.2014.06.001_bib5","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2014.06.001_bib6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2014.06.001_bib7","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2014.06.001_bib8","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2014.06.001_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2014.06.001_bib10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.tcm.2014.06.001_bib11","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.jacc.2005.06.077","article-title":"Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation","volume":"46","author":"Waldo","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2014.06.001_bib12","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/archinte.160.7.967","article-title":"Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities","volume":"160","author":"Samsa","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.tcm.2014.06.001_bib13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.18553\/jmcp.2013.19.4.302","article-title":"The costs of warfarin underuse and nonadherence in patients with atrial fibrillation: a commercial insurer perspective","volume":"19","author":"Casciano","year":"2013","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.tcm.2014.06.001_bib14","doi-asserted-by":"crossref","DOI":"10.4159\/harvard.9780674282100","article-title":"Warfarin and aspirin use for stroke prevention among patients with atrial fibrillation: the US national health and wellness survey","author":"Goren","year":"2013","journal-title":"Am J Ther"},{"key":"10.1016\/j.tcm.2014.06.001_bib15","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation","volume":"61","author":"Blackshear","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.tcm.2014.06.001_bib16","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2014.06.001_bib17","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/jama.1949.02900440011003","article-title":"Resection of the left auricular appendix; a prophylaxis for recurrent arterial emboli","volume":"140","author":"Madden","year":"1949","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.tcm.2014.06.001_bib18","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/j.athoracsur.2011.08.044","article-title":"Left atrial appendage occlusion: lessons learned from surgical and transcatheter experiences","volume":"92","author":"Chatterjee","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.tcm.2014.06.001_bib19","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0735-1097(00)00765-8","article-title":"Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiograhic study","volume":"36","author":"Katz","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2014.06.001_bib20","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jacc.2008.03.067","article-title":"Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography","volume":"52","author":"Kanderian","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2014.06.001_bib21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1510\/icvts.2009.227991","article-title":"Should patients undergoing cardiac surgery with atrial fibrillation have left atrial appendage exclusion?","volume":"10","author":"Dawson","year":"2010","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.tcm.2014.06.001_bib22","first-page":"45","article-title":"Rationale and design of the left atrial appendage occlusion study (LAAOS) III","volume":"3","author":"Whitlock","year":"2014","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.tcm.2014.06.001_bib23","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jtcvs.2008.06.002","article-title":"A novel device for left atrial appendage exclusion: the third-generation atrial exclusion device","volume":"136","author":"Fumoto","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.tcm.2014.06.001_bib24","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2014.06.001_bib25","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.112.114389","article-title":"Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman left atrial appendage system for embolic protection in patients with atrial fibrillation) trial","volume":"127","author":"Reddy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2014.06.001_bib26","article-title":"Long term results of PROTECT AF: the mortality effects of left atrial appendage closure versus warfarin for stroke prophylaxis in AF","author":"Reddy","year":"2013","journal-title":"Heart Rhythm Soc Sci Sessions"},{"key":"10.1016\/j.tcm.2014.06.001_bib27","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.jacc.2013.01.061","volume":"61","author":"Alli","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2014.06.001_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/CIRCULATIONAHA.110.976449","article-title":"Safety of percutaneous left atrial appendage closure: results from the Watchman left atrial appendage system for embolic protection in patients with AF (PROTECT AF) clinical trial and the Continued Access Registry","volume":"123","author":"Reddy","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.tcm.2014.06.001_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the WATCHMAN left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2014.06.001_bib30","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/ccd.22764","article-title":"Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience","volume":"77","author":"Park","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2014.06.001_bib31","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.4244\/EIJV8I9A167","article-title":"The Amplatzer cardiac plug 2 for left atrial appendage occlusion: novel features and first-in-man experience","volume":"8","author":"Freixa","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.tcm.2014.06.001_bib32","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCINTERVENTIONS.109.914978","article-title":"Catheter-based left atrial appendage (LAA) ligation for the prevention of embolic events arising from the LAA: initial experience in a canine model","volume":"3","author":"Lee","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2014.06.001_bib33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jacc.2012.06.046","article-title":"Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience","volume":"62","author":"Bartus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2014.06.001_bib34","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.amjcard.2012.11.061","article-title":"Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation","volume":"111","author":"Massumi","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2014.06.001_bib35","doi-asserted-by":"crossref","unstructured":"Price MJ, Burkhardt JD, Di Biase L, Goldstein J, Knight BP, Lin AC, et al. Safety and early efficacy of the lariat procedure: results from the U.S. left atrial appendage ligation consortium. J Am Coll Cardiol: [in press].","DOI":"10.1016\/j.jacc.2014.03.057"},{"key":"10.1016\/j.tcm.2014.06.001_bib36","article-title":"Percutaneous management of late leak after lariat transcatheter ligation of the left atrial appendage in patients with atrial fibrillation at high risk for stroke","author":"Mosley","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2014.06.001_bib37","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.tcm.2014.06.001_bib38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","volume":"57","author":"Lip","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2014.06.001_bib39","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1093\/eurheartj\/ehs292","article-title":"Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit","volume":"33","author":"Gangireddy","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2014.06.001_bib40","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.jacc.2013.03.035","article-title":"Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA plavix feasibility study with watchman left atrial appendage closure technology)","volume":"61","author":"Reddy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2014.06.001_bib41","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2014.06.001_bib42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/europace\/eus413","article-title":"Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey","volume":"15","author":"Lip","year":"2013","journal-title":"Europace"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173814000474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173814000474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T18:31:08Z","timestamp":1597948268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173814000474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1050173814000474"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2014.06.001","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanical closure devices for atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2014.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}